GALVUS (vildagliptin), a new type
2 diabetes medication, will be
available on the PBS from 01 Aug.
The medication works in
combination with metformin, a
sulfonylurea or pioglitizone to
effectively reduce blood glucose
levels, and has been found in
combination with metformin to
deliver significant HBA1c reductions
compared to metformin plus
placebo in patients not controlled
on metformin alone.
From 01 Aug Galvus will be on
the PBS as an Authority Required
(Streamlined) item for dual oral
combination therapy.The above article was sent to subscribers in Pharmacy Daily's issue from 07 Jul 10 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 07 Jul 10
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.